Clinical Trials Logo

Clinical Trial Summary

For intrauterine device (IUD) insertion, currently there are no standardized clinical guidelines for pain management. The investigators aim to explore whether adequate pain relief is possible through self-administered, non-invasive means alone. Reducing pain associated with IUD insertion may benefit patients and providers. When patients are comfortable during their procedure, it is likely the provider can more quickly and with fewer complications perform the insertion. The investigators propose to explore the effect of a locally applied vaginal lidocaine gel in place of the standard of care pain management, no intervention, prior to IUD insertions. This is a superiority, blinded, randomized controlled trial.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02738203
Study type Interventional
Source Stanford University
Contact
Status Completed
Phase Phase 3
Start date June 1, 2016
Completion date October 19, 2017

See also
  Status Clinical Trial Phase
Completed NCT02708251 - Glyceryl Trinitrate Versus Lidocaine Cream for IUD Insertion Phase 4
Completed NCT02141321 - Sub Lingual Misoprostol Before IUD Insertion in Women With Only Previous Cesarean Section Phase 2/Phase 3
Not yet recruiting NCT03473717 - Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method N/A
Recruiting NCT05204979 - Vaginal Vs Subling Misoprost Before Iud Insertion in Women With Previous CS
Completed NCT04441333 - Usability, Safety and Efficacy of AspivixTM N/A
Completed NCT02904915 - Paracervical Block Versus No Paracervical Block During IUD Insertion Phase 4
Completed NCT04046302 - Vaginal Dinoprostone Administration Prior to an Intrauterine Device Insertion in Multiparous Women. Phase 4
Completed NCT04441281 - Usability, Safety and Efficacy of AspivixTM (Comparative Study) N/A